Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M600Revenue $M13.6Net Margin (%)-332.1Z-Score0.5
Enterprise Value $M557EPS $-0.7Operating Margin %-336.4F-Score2
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-332.1Higher ROA y-yN
Price/Book7.910-y EBITDA Growth Rate %-6.8Quick Ratio1.5Cash flow > EarningsY
Price/Sales39.55-y EBITDA Growth Rate %4.1Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-44.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-93.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M71.9ROI % (ttm)-126.5Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRXGeorge Soros 2014-06-30 Sold Out -0.01%$7.37 - $12.52
($9.68)
$ 8.30-17%Sold Out0
BCRXGeorge Soros 2014-03-31 Buy 0.01%$7.6 - $12.83
($10.56)
$ 8.30-27%New holding59,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Babu Yarlagadda SSenior VP - Drug Discovery 2015-03-19Sell12,105$10.16-18.31view
Babu Yarlagadda SSenior VP - Drug Discovery 2015-03-05Sell37,400$10.59-21.62view
Babu Yarlagadda SSenior VP - Drug Discovery 2015-03-04Sell10,495$10.5-20.95view
Hutson Nancy JDirector 2015-02-20Buy10,000$10.27-19.18view
Sheridan William PSenior VP - CMO 2014-12-30Sell128,399$12.36-32.85view
STAAB THOMAS R IISenior Vice President and CFO 2014-12-29Sell9,500$12.56-33.92view
STAAB THOMAS R IISenior Vice President and CFO 2014-08-27Sell10,000$13.58-38.88view
STAAB THOMAS R IISenior Vice President and CFO 2014-07-01Sell3,125$13-36.15view
STAAB THOMAS R IISenior Vice President and CFO 2014-06-23Sell3,125$12.49-33.55view
STAAB THOMAS R IISenior Vice President and CFO 2014-06-17Sell3,125$12-30.83view

Press Releases about BCRX :

    Quarterly/Annual Reports about BCRX:

    News about BCRX:

    Articles On GuruFocus.com
    comment on BCRX Mar 02 2013 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K/A) Jan 19 2011 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 2,500 Shares Aug 06 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares Jun 04 2010 
    BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares May 05 2010 
    BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 38,553 Shares Apr 30 2010 

    More From Other Websites
    Cramer Remix: These stocks are soaring again Mar 19 2015
    Lightning Round: This slammed over false Fed fears Mar 19 2015
    BIOCRYST PHARMACEUTICALS INC Financials Mar 10 2015
    BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 10 2015
    10-K for BioCryst Pharmaceuticals, Inc. Mar 04 2015
    BIOCRYST PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 02 2015
    ZMapp Ebola Trial Starts In Liberia: Is It Too Late? Mar 01 2015
    U.S., Liberia kick off trial of Ebola drug ZMapp Feb 27 2015
    BioCryst to Present at Two Upcoming Investor Conferences Feb 26 2015
    [video]'Mad Money' Lightning Round: Buy Enbridge Energy Partners Feb 24 2015
    Cramer Remix: Where's the Nasdaq bubble? Feb 23 2015
    Lightning Round: Don't listen to this CEO Feb 23 2015
    Biocryst crosses milestone with U.S. sales Feb 19 2015
    BioCryst Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today Feb 18 2015
    BioCryst reports 4Q loss Feb 18 2015
    BioCryst reports 4Q loss Feb 18 2015
    BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 18 2015
    BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results Feb 18 2015
    Q4 2014 BioCryst Pharmaceuticals Inc Earnings Release - Before Market Open Feb 18 2015
    BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK